Proventil and Exjade drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Proventil (albuterol) and Exjade (deferasirox). Common drug interactions include basal cell carcinoma among females and anisocytosis among males.
The phase IV clinical study analyzes what interactions people have when they take Proventil and Exjade. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Proventil?
Proventil has active ingredients of albuterol. It is often used in asthma. eHealthMe is studying from 16,110 Proventil users. Check the latest studies of Proventil.
What is Exjade?
Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,456 Exjade users. Check the latest studies of Exjade.
11 people who take Proventil and Exjade together, and have interactions are studied.

What are the common drug interactions of Proventil and Exjade, by gender? *:
female:
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Nasal discomfort
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Renal cell carcinoma (a kidney cancer)
- Abdominal pain upper
- Dermatitis allergic (inflammation of the skin due allergic reaction)
- Nausea (feeling of having an urge to vomit)
- Pruritus (severe itching of the skin)
- Renal failure (kidney dysfunction)
male:
- Anisocytosis (patient's red blood cells are of unequal size)
- Dyspnoea (difficult or laboured respiration)
- Mean cell haemoglobin decreased (less than normal haemoglobin per red blood cell in a sample of blood)
- Monocyte percentage increased
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Platelet count decreased
- Poikilocytosis (presence of poikilocytes in the blood)
- Red blood cell count decreased
- Red cell distribution width increased
- White blood cell count decreased
What are the common drug interactions of Proventil and Exjade, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Haematocrit decreased
- Haemoglobin decreased
- Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
- Haptoglobin decreased
- Hospitalisation
- Lymphocyte percentage increased
- Mean cell haemoglobin concentration decreased (less concentration of haemoglobin in a given volume of packed red blood cells)
- Mean cell haemoglobin decreased (less than normal haemoglobin per red blood cell in a sample of blood)
- Monocyte percentage increased
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
- Nasal discomfort
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Renal cell carcinoma (a kidney cancer)
- Ill-defined disorder
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
What are the existing conditions these people have? *
- Peripheral Swelling: 3 people, 27.27%
- Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 3 people, 27.27%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 27.27%
- Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 3 people, 27.27%
- Anaemia (lack of blood): 3 people, 27.27%
- Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 18.18%
- Cough: 2 people, 18.18%
- Wheezing (a high-pitched whistling sound made while you breath): 1 person, 9.09%
- Hereditary Haemochromatosis (hereditary condition -excessive amounts of iron accumulate in the body tissues): 1 person, 9.09%
- Haemochromatosis (body to absorb more iron than usual from food): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Proventil and Exjade?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Proventil and Exjade:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Proventil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Exjade:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Proventil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Exjade and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
- Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
- Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
- Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
- Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
- Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on albuterol and deferasirox (the active ingredients of Proventil and Exjade, respectively), and Proventil and Exjade (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Thiola cause Death? - 12 seconds ago
- Drug interactions of Detrol and Protonix - 24 seconds ago
- Could Azathioprine cause Vomiting Aggravated? - 26 seconds ago
- Could Cider Vinegar cause Nasopharyngitis? - 36 seconds ago
- Drug interactions of Soma and Zyrtec-D 12 Hour - 46 seconds ago
- Indian Tumeric vs. Flexeril, side effect and effectiveness comparison - 55 seconds ago
- Could Avapro cause Ventricular Tachycardia? - 55 seconds ago
- Drug interactions of Enalapril Maleate and Cytotec - 57 seconds ago
- Drug interactions of Riboflavin and Lantus - 57 seconds ago
- Drug interactions of Potassium Iodide and Digoxin - a minute ago